Scientist with flask

LEBAO

Leibniz Research Laboratories for Biotechnology and Artificial Organs

Bioreactor

LEBAO

Leibniz Research Laboratories for Biotechnology and Artificial Organs

Gruppenbild LEBAO 2019

LEBAO

Leibniz Research Laboratories for Biotechnology and Artificial Organs

I11 - LEBAO / HBZ Building

LEBAO

Leibniz Research Laboratories for Biotechnology and Artificial Organs

LEBAO

About us

LEBAO Logo

The Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO) were founded by Professor Axel Haverich at the Hannover Medical School (MHH) in 1996 finaced through the prestigious Leibniz prize awarded by the DFG.

The LEBAO is one of the central pillars of REBIRTH - Research Center for Translational Regenerative Medicine and is closely linked to the Department of Cardiothoracic, Transplantation and Vascular Surgery at the MHH. The resulting synergies between application-driven basic research and clinical practice are supported by the co-directorship of a clinical director, Professor Axel Haverich, and a research director, Professor Ulrich Martin.

Here at LEBAO, we study various aspects of regenerative medicine and organ transplantation. The close link between basic research and clinical practice enables targeted development work and corresponding innovative therapy concepts to be quickly implemented in clinical practice. Under the direction of Prof. Ulrich Martin we are currently working on a variety of different research projects in several working groups. The great majority of the projects are in the area of development of novel therapies for the treatment of cardiovascular and respiratory diseases.

Projects in all areas of research aim at the development of new therapies for the treatment of cardiovascular and respiratory diseases. We collaborate closely with other Groups within the MHH and REBIRTH, as well as with the University of Hannover, corlife oHG and numerous other national and international scientific institutions and industry partners.


News

Veronika Fricke and Preaploy Pongpamorn

Graduation 2022 Summer

We congratulate Veronika Fricke and Preaploy Pongpamorn on their excellent doctoral thesis which was passed on June 24, 2022!

 

Further Informations
COFONI Logo

COFONI - Lower Saxony

LEBAO is part of the Covid 19 research network. In the latest round of funding, the state of Lower Saxony is supporting four studies on Long Covid with two million euros.

Further Information
Abdulai Usman and Sanja Sladic

Graduation 2022

We congratulate Abdulai Usman and Sanja Sladic for completing their doctoral theses with excellent results on January 14, 2022!

Further Information

Advanced Protocol

Novel publication on an advanced protocol for the generation of heart-forming organoids from human pluripotent stem cells

Further information
photo of the certificate

Teaching Award 2021

We are proud about the teaching price of the student body 2021 for our module "Stem Cell Research and Tissue Engineering"

Further information

Embryonic development in cell culture

MHH research group can for the first time reproduce early heart development in cell culture dishes using human stem cells

Further information

Scalable process for Differentiation

Scalable process for differentiating pluripotent stem cells into definitive endoderm

Further information

Generation of human induced pluripotent stem cell lines

Check out our new paper in Stemcell Reseach about encoding for genetically encoded calcium indicators RCaMP1h and GCaMP6f

Further Information

Research groups

There are currently six research groups at the LEBAO. These use a variety of different technologies, e.g. reprogramming of somatic cells for the production of induced pluripotent stem cells (iPS cells), so-called "gene editing" for the targeted genetic modification of cells, scalable bioreactor systems for stem cell expansion and differentiation, or tissue engineering for production of cardiovascular tissue and organ replacements. Long-term goals of our research include the elucidation of disease mechanisms, the development of new drugs and novel cell- and gene-based therapies for regeneration and the repair of damaged organs, especially in the cardiovascular field.

Research

REBIRTH

The former cluster of excellence REBIRTH (2006 - 2019) continues as 'REBIRTH - Research Center for Translational Regenerative Medicine'.

Further Information about REBIRTH

iCARE

The joint research project iCARE aims to prepare the first worldwide clinical application of iPSC-derived cardiomyocytes for heart repair.

Further information about iCARE

3D-Heart-2B

The target of 3D-Heart-2B is to develop a biological cardiac support system with the help of induced pluripotent stem cells.

Further information about 3D-Heart-2B

Further projects

In addition to REBIRTH, iCARE and 3D-Heart-2D, LEBAO is also involved in many other projects - you can find an overview here.

Further information

Contact

How to find us

Location

Entranceway gynecological clinic

Building J11, Level H0


Directions to MHH
Contact information

LEBAO Office

Tel. +49 511 532 8820 or +49 511 532 8821

 

LinkedIn: Lebao-MHH